Renal Safety of Telminuvo, a Single Pill Combination of Telmisartan and S-amlodipine, in Korean Hypertensive Patients: A Multicenter, Retrospective Cohort Study

  • Abstract
  • Literature Map
  • References
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

BackgroundEffective blood pressure (BP) control is vital for preventing target organ damage, and combination therapy offers added benefits when single-agent treatment is insufficient. This cohort study examined whether Telminuvo, a single-pill combination of telmisartan and S-amlodipine, effectively maintains kidney function as a target organ in a large cohort of Korean patients.MethodsA total of 4,934 patients from 30 hospitals were treated with Telminuvo for over six months, with BP, estimated glomerular filtration rate (eGFR), electrolyte levels, and adverse events monitored throughout the study period.ResultsAmong the participants, 1,463 (29.7%) used Telminuvo for less than 1 year, while the remainder used it for longer. At baseline, the systolic and diastolic BP averaged 140.2 ± 18.4 mmHg and 82.1 ± 13.4 mmHg, respectively, which significantly decreased to approximately 130 and 75 mmHg after the initiation of treatment. The baseline eGFR of 79.3 mL/min/1.73 m2 remained stable over three years, regardless of the initial eGFR levels. Within the first six months, acute kidney injury (defined as either a ≥ 0.3 mg/dL increase in serum creatinine or a ≥ 50% increase from baseline) occurred in 6.6% of patients, while hyperkalemia (defined as serum potassium levels > 5.5 mmol/L) was observed in 3.2% of patients.ConclusionThis cohort study demonstrates that Telminuvo effectively reduces blood pressure without compromising kidney function. Furthermore, the findings provide additional insights into drug-related adverse events, which will be valuable for clinicians in the real-world prescribing of Telminuvo.

ReferencesShowing 10 of 30 papers
  • Cite Count Icon 36
  • 10.1016/j.mcna.2009.02.003
Hypertension and Myocardial Ischemia
  • May 1, 2009
  • Medical Clinics of North America
  • Brian P Murphy + 2 more

  • Cite Count Icon 369
  • 10.1053/j.ajkd.2003.09.026
Measured and estimated GFR in healthy potential kidney donors
  • Jan 1, 2004
  • American Journal of Kidney Diseases
  • Andrew D Rule + 6 more

  • Cite Count Icon 36
  • 10.1038/hr.2016.183
Clinical roles of calcium channel blockers in ischemic heart diseases.
  • Jan 26, 2017
  • Hypertension Research
  • Daisuke Sueta + 2 more

  • Open Access Icon
  • Cite Count Icon 16
  • 10.23876/j.krcp.2018.37.1.49
Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease.
  • Mar 31, 2018
  • Kidney Research and Clinical Practice
  • Shin Young Ahn + 9 more

  • Open Access Icon
  • PDF Download Icon
  • Cite Count Icon 3
  • 10.7759/cureus.41398
Comparing Triple Combination Drug Therapy and Traditional Monotherapy for Better Survival in Patients With High-Risk Hypertension: A Systematic Review
  • Jul 5, 2023
  • Cureus
  • Mustafa Abrar Zaman + 9 more

  • Open Access Icon
  • Cite Count Icon 638
  • 10.1097/hjh.0000000000002453
2020 International Society of Hypertension global hypertension practice guidelines.
  • Jun 1, 2020
  • Journal of Hypertension
  • Thomas Unger + 12 more

  • Cite Count Icon 241
  • 10.1038/s41569-020-00437-9
Lifestyle interventions for the prevention and treatment of hypertension
  • Oct 9, 2020
  • Nature Reviews Cardiology
  • Pedro L Valenzuela + 6 more

  • Open Access Icon
  • Cite Count Icon 183
  • 10.7326/0003-4819-151-1-200907070-00122
Effect of Telmisartan on Renal Outcomes
  • May 18, 2009
  • Annals of Internal Medicine
  • Johannes F.E Mann + 17 more

  • Cite Count Icon 34
  • 10.1016/j.mcna.2009.02.005
Hypertension and Cardiac Failure in its Various Forms
  • May 1, 2009
  • Medical Clinics of North America
  • Krishna K Gaddam + 4 more

  • Open Access Icon
  • Cite Count Icon 2516
  • 10.1038/s41581-019-0244-2
The global epidemiology of hypertension.
  • Feb 5, 2020
  • Nature Reviews Nephrology
  • Katherine T Mills + 2 more

Similar Papers
  • Research Article
  • Cite Count Icon 125
  • 10.1038/ki.2011.119
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
  • Aug 1, 2011
  • Kidney International
  • Maria V Irazabal + 8 more

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

  • Front Matter
  • Cite Count Icon 34
  • 10.1016/j.jhep.2013.05.035
Acute kidney injury (AKI) in cirrhosis: Should we change current definition and diagnostic criteria of renal failure in cirrhosis?
  • May 31, 2013
  • Journal of Hepatology
  • Vicente Arroyo

Acute kidney injury (AKI) in cirrhosis: Should we change current definition and diagnostic criteria of renal failure in cirrhosis?

  • Research Article
  • Cite Count Icon 620
  • 10.1038/sj.ki.5001527
Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery
  • Jul 1, 2006
  • Kidney International
  • C.R Parikh + 8 more

Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery

  • Front Matter
  • Cite Count Icon 178
  • 10.1053/j.ajkd.2007.05.008
Improving Outcomes From Acute Kidney Injury: Report of an Initiative
  • Jul 1, 2007
  • American Journal of Kidney Diseases
  • Adeera Levin + 6 more

Improving Outcomes From Acute Kidney Injury: Report of an Initiative

  • Research Article
  • Cite Count Icon 50
  • 10.1038/ki.2012.227
Oral bisphosphonate use in the elderly is not associated with acute kidney injury
  • Oct 1, 2012
  • Kidney International
  • Andrew W.Y Shih + 12 more

Oral bisphosphonate use in the elderly is not associated with acute kidney injury

  • Research Article
  • Cite Count Icon 14
  • 10.1542/pir.35.1.30
Acute Kidney Injury
  • Jan 1, 2014
  • Pediatrics In Review
  • David T Selewski + 1 more

Acute Kidney Injury

  • Research Article
  • Cite Count Icon 17
  • 10.1542/pir.35-1-30
Acute Kidney Injury
  • Jan 1, 2014
  • Pediatrics in Review
  • D T Selewski + 1 more

1. David T. Selewski, MD* 2. Jordan M. Symons, MD† 1. *Department of Pediatrics and Communicable Diseases, Division of Nephrology, C.S. Mott Children’s Hospital, University of Michigan, Ann Arbor, MI. 2. †Department of Pediatrics, Division of Nephrology, University of Washington School of Medicine, Seattle, WA. * Abbreviations: ACE: : angiotensin-converting enzyme AKI: : acute kidney injury AKIN: : Acute Kidney Injury Network ANCA: : antineutrophil cytoplasmic antibody ATN: : acute tubular necrosis ECG: : electrocardiogram FEurea: : fractional excretion of urea FENa: : fractional excretion of sodium KDIGO: : Kidney Disease: Improving Global Outcomes NSAID: : nonsteroidal anti-inflammatory drug RIFLE: : Risk, Injury, Failure, Loss, and End-stage The term acute kidney injury has replaced acute renal failure and represents a spectrum of clinically meaningful kidney damage. After completing this article, readers should be able to: 1. Recognize and define the spectrum of acute kidney injury (AKI). 2. Understand the diagnostic approach and be able to differentiate the main causes of AKI. 3. Understand the complications of AKI and the treatment of a child with AKI. Acute kidney injury (AKI), formerly called acute renal failure, is characterized by multiple abnormalities, including increases in serum creatinine and blood urea nitrogen, electrolyte abnormalities, acidosis, and difficulties with fluid management. We have come to realize that what was previously thought to be relatively minor damage to the kidney can have significant short-term effects on morbidity and mortality and potential long-term implications for the development of chronic kidney disease. Thus, the term acute kidney injury has replaced acute renal failure , suggesting the spectrum of kidney damage that can occur. ### Definition AKI is classically defined as an acute decrease in glomerular filtration rate, which results in an increase in serum creatinine. It is important to recognize the limitations of creatinine as a marker of AKI because an increase in creatinine can be delayed by as much as 48 hours after damage to the kidney has occurred. Despite this limitation, change in creatinine remains the gold standard for the diagnosis of AKI. An evolution in the definition of AKI to better understand, characterize, and study the disease spectrum, has occurred, which has sought to capture the clinical importance of even small variations in kidney function. In addition, previous definitions used in the literature were widely disparate; this …

  • Front Matter
  • Cite Count Icon 77
  • 10.1053/j.ajkd.2008.07.008
NGAL in Acute Kidney Injury: From Serendipity to Utility
  • Aug 23, 2008
  • American Journal of Kidney Diseases
  • Prasad Devarajan

NGAL in Acute Kidney Injury: From Serendipity to Utility

  • Research Article
  • Cite Count Icon 147
  • 10.1002/lt.21877
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation
  • Oct 28, 2009
  • Liver Transplantation
  • Michael R Charlton + 15 more

Michael R. Charlton, William J. Wall, Akinlolu O. Ojo, Pere Gines, Stephen Textor, Fuad S. Shihab, Paul Marotta, Marcelo Cantarovich, James D. Eason, Russell H. Wiesner, Michael A. Ramsay, Juan C. Garcia-Valdecasas, James M. Neuberger, Sandy Feng, Connie L. Davis, Thomas A. Gonwa, and the International Liver Transplantation Society Expert Panel Mayo Clinic, Rochester MN; Department of General Surgery, London Health Science Center, London, Ontario, Canada; Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI; Liver Unit, Hospital Clinic, University of Barcelona School of Medicine, Barcelona, Spain; Department of Nephrology, University of Utah School of Medicine, Salt Lake City, UT; Medical School, University of Western Ontario, London, Ontario, Canada; Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada; Transplant Institute, University of Tennessee, Memphis, TN; Baylor University Medical Center, Dallas, TX; Hospital Clinic I Provincial, Barcelona, Spain; Queen Elizabeth Hospital, Birmingham, England; Department of Transplant Surgery, University of California San Francisco Medical Center, San Francisco, CA; Department of Medicine, University of Washington Medical Center, Seattle, WA; and Mayo Clinic, Jacksonville, FL

  • Research Article
  • Cite Count Icon 53
  • 10.1016/j.jhep.2010.12.001
Immunosuppression in liver transplant recipients with renal impairment
  • Dec 9, 2010
  • Journal of Hepatology
  • C Duvoux + 1 more

Immunosuppression in liver transplant recipients with renal impairment

  • Front Matter
  • Cite Count Icon 5
  • 10.2217/bmm.14.89
Novel biomarkers of acute kidney injury: time for implementation?
  • Dec 1, 2014
  • Biomarkers in Medicine
  • Zoltan H Endre

Novel biomarkers of acute kidney injury: time for implementation?

  • Front Matter
  • Cite Count Icon 30
  • 10.1053/j.ajkd.2007.12.004
Multimodality Prevention of Contrast-Induced Acute Kidney Injury
  • Feb 1, 2008
  • American Journal of Kidney Diseases
  • Peter A Mccullough

Multimodality Prevention of Contrast-Induced Acute Kidney Injury

  • Research Article
  • Cite Count Icon 161
  • 10.1053/j.ackd.2012.10.003
Perioperative Acute Kidney Injury
  • Dec 22, 2012
  • Advances in Chronic Kidney Disease
  • Charuhas V Thakar

Perioperative Acute Kidney Injury

  • Research Article
  • Cite Count Icon 45
  • 10.1053/j.ackd.2008.04.007
Progression From Acute Kidney Injury to Chronic Kidney Disease: A Pediatric Perspective
  • Jun 17, 2008
  • Advances in chronic kidney disease
  • Stuart L Goldstein + 1 more

Progression From Acute Kidney Injury to Chronic Kidney Disease: A Pediatric Perspective

  • Research Article
  • Cite Count Icon 39
  • 10.1016/j.bbmt.2010.07.010
Pretransplant Predictors and Posttransplant Sequels of Acute Kidney Injury after Allogeneic Stem Cell Transplantation
  • Jul 22, 2010
  • Biology of Blood and Marrow Transplantation
  • Yuki Kagoya + 3 more

Pretransplant Predictors and Posttransplant Sequels of Acute Kidney Injury after Allogeneic Stem Cell Transplantation

More from: Electrolytes & Blood Pressure : E & BP
  • Research Article
  • 10.5049/ebp.2025.23.e3
Cytotoxic Lesions of the Corpus Callosum Preceding Osmotic Demyelination Syndrome in Hypernatremia and Hyperosmolar Hyperglycemic State: A Case Report
  • Jun 1, 2025
  • Electrolytes & Blood Pressure : E & BP
  • Hye Jin Park + 7 more

  • Research Article
  • 10.5049/ebp.2025.23.e2
A Case of Cystinuria With Compound Heterozygous Mutations Both in SLC3A1 and SLC7A9 Genes
  • Jun 1, 2025
  • Electrolytes & Blood Pressure : E & BP
  • Sang Heon Suh + 6 more

  • Research Article
  • 10.5049/ebp.2025.23.e1
Renal Safety of Telminuvo, a Single Pill Combination of Telmisartan and S-amlodipine, in Korean Hypertensive Patients: A Multicenter, Retrospective Cohort Study
  • May 8, 2025
  • Electrolytes & Blood Pressure : E & BP
  • Hongran Moon + 6 more

  • Open Access Icon
  • Supplementary Content
  • Cite Count Icon 8
  • 10.5049/ebp.2022.20.2.64
Management for Electrolytes Disturbances during Continuous Renal Replacement Therapy
  • Dec 1, 2022
  • Electrolytes & Blood Pressure : E & BP
  • Song In Baeg + 3 more

  • Open Access Icon
  • Supplementary Content
  • 10.5049/ebp.2022.20.2.49
Bartter Syndrome: Perspectives of a Pediatric Nephrologist
  • Dec 1, 2022
  • Electrolytes & Blood Pressure : E & BP
  • Naye Choi + 1 more

  • Open Access Icon
  • Supplementary Content
  • 10.5049/ebp.2022.20.2.57
Blood Pressure Control in Elderly Chronic Kidney Disease Patients
  • Dec 1, 2022
  • Electrolytes & Blood Pressure : E & BP
  • Jae Won Yang

  • Open Access Icon
  • Research Article
  • Cite Count Icon 2
  • 10.5049/ebp.2022.20.1.17
Potassium Channel Syndrome Caused by Nicorandil in Chronic Kidney Disease: A Case Report and Literature Review
  • Jun 1, 2022
  • Electrolytes & Blood Pressure : E & BP
  • Ji-Eun Kim + 4 more

  • Open Access Icon
  • Supplementary Content
  • Cite Count Icon 14
  • 10.5049/ebp.2022.20.1.1
Skin Sodium and Blood Pressure Regulation
  • Jun 1, 2022
  • Electrolytes & Blood Pressure : E & BP
  • Jong Hyun Jhee + 2 more

  • Open Access Icon
  • Supplementary Content
  • Cite Count Icon 5
  • 10.5049/ebp.2022.20.1.21
Korean Society of Nephrology 2022 Recommendations on Controversial Issues in Diagnosis and Management of Hyponatremia
  • Jun 1, 2022
  • Electrolytes & Blood Pressure : E & BP
  • Yeonhee Lee + 17 more

  • Open Access Icon
  • Supplementary Content
  • Cite Count Icon 2
  • 10.5049/ebp.2022.20.1.10
Practical Issues in the Management of Polycystic Kidney Disease: Blood Pressure and Water Balance
  • Jun 1, 2022
  • Electrolytes & Blood Pressure : E & BP
  • Hayne Cho Park + 1 more

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.

Search IconWhat is the difference between bacteria and viruses?
Open In New Tab Icon
Search IconWhat is the function of the immune system?
Open In New Tab Icon
Search IconCan diabetes be passed down from one generation to the next?
Open In New Tab Icon